RT @uptoTate: UPSTREAM results #OP0223 suggest that the newly developed and preliminary validated MSKUS PsA dz activity

Social Author Image
https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3.jpg
Tweet Author
uptoTate
Social Author Name
Dr. Rachel Tate
Tweet Content
UPSTREAM results #OP0223 suggest that the newly developed and preliminary validated MSKUS PsA dz activity and damage scores could be used in observational and controlled trials. #EULAR2021 @RheumNow https://t.co/Tw7OWyMcgX https://t.co/WiT0yGwVqK
Links
http://ow.ly/dBaI50F2i4y
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×